PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human Cathepsin D (carrier-free), 25 µg
Recombinant Human Cathepsin E (carrier-free), 10 μg
Recombinant Human Cathepsin E (carrier-free), 25 μg
Recombinant Human CCL1 (I-309) (carrier-free), 10 μg
Recombinant Human CCL1 (I-309) (carrier-free), 100 μg
Recombinant Human CCL1 (I-309) (carrier-free), 25 μg
Recombinant Human CCL1 (I-309) (carrier-free), 500 μg
Recombinant Human CCL11 (Eotaxin) (carrier-free), 10 μg
Recombinant Human CCL11 (Eotaxin) (carrier-free), 100 μg
Recombinant Human CCL11 (Eotaxin) (carrier-free), 25 μg
Recombinant Human CCL17 (TARC) (carrier-free), 10 μg
Recombinant Human CCL17 (TARC) (carrier-free), 100 μg
Recombinant Human CCL17 (TARC) (carrier-free), 25 μg
Recombinant Human CCL17 (TARC) (ELISA Std.), 4 pack
Recombinant Human CCL19 (MIP-3β) (carrier-free), 10 μg
Recombinant Human CCL19 (MIP-3β) (carrier-free), 100 μg